SP
Symmetry Partners Portfolio holdings
AUM
$813M
This Quarter Return
+15.29%
1 Year Return
+11.36%
3 Year Return
+48.13%
5 Year Return
+85.09%
10 Year Return
–
AUM
$800M
AUM Growth
+$800M
(+78%)
Cap. Flow
+$287M
Cap. Flow
% of AUM
35.85%
Top 10 Holdings %
Top 10 Hldgs %
45.78%
Holding
365
New
87
Increased
119
Reduced
71
Closed
69
Top Buys
Top Sells
| 1 |
Microsoft
MSFT
|
$3.58M |
| 2 |
Meta Platforms (Facebook)
META
|
$3.22M |
| 3 |
TSMC
TSM
|
$3.2M |
| 4 |
Apple
AAPL
|
$3.12M |
| 5 |
Bank of America
BAC
|
$2.28M |
Sector Composition
| 1 | Technology | 7.37% |
| 2 | Healthcare | 3.59% |
| 3 | Industrials | 2.64% |
| 4 | Consumer Staples | 2.29% |
| 5 | Consumer Discretionary | 2.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NVIDIA
NVDA
$4.24T
| $2.51M | 0.31% | 6,617 +2,629 | +66% | +$999K |
|
52
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $2.29M | 0.29% | 39,058 +9,465 | +32% | +$555K |
|
|
FM
53
DELISTED
iShares Frontier and Select EM ETF
FM
| $2.29M | 0.29% | 94,560 +1,933 | +2% | +$46.8K |
|
54
Vanguard Global ex-US Real Estate ETF
VNQI
$3.55B
| $2.13M | 0.27% | 45,690 +2,172 | +5% | +$101K |
|
55
Costco
COST
$418B
| $1.93M | 0.24% | 6,378 +132 | +2% | +$40K |
|
56
AbbVie
ABBV
$372B
| $1.93M | 0.24% | 19,627 +15,775 | +410% | +$1.55M |
|
57
Johnson & Johnson
JNJ
$427B
| $1.76M | 0.22% | +12,498 | New | +$1.76M |
|
58
Verizon
VZ
$186B
| $1.64M | 0.2% | +29,694 | New | +$1.64M |
|
|
59
Meta Platforms (Facebook)
META
$1.86T
| $1.61M | 0.2% | 7,094 -14,175 | -67% | -$3.22M |
|
60
Accenture
ACN
$162B
| $1.52M | 0.19% | 7,063 +731 | +12% | +$157K |
|
61
Adobe
ADBE
$151B
| $1.51M | 0.19% | +3,474 | New | +$1.51M |
|
62
Qualcomm
QCOM
$173B
| $1.46M | 0.18% | 16,028 +1,164 | +8% | +$106K |
|
63
Medtronic
MDT
$119B
| $1.27M | 0.16% | 13,892 +1,901 | +16% | +$174K |
|
64
Target
TGT
$43.6B
| $1.26M | 0.16% | 10,519 -407 | -4% | -$48.8K |
|
65
T-Mobile US
TMUS
$284B
| $1.25M | 0.16% | +11,991 | New | +$1.25M |
|
66
Lam Research
LRCX
$127B
| $1.24M | 0.15% | 3,819 -37 | -1% | -$12K |
|
67
Amgen
AMGN
$155B
| $1.22M | 0.15% | 5,179 +3,949 | +321% | +$932K |
|
68
Lockheed Martin
LMT
$106B
| $1.21M | 0.15% | 3,316 -772 | -19% | -$282K |
|
69
Bristol-Myers Squibb
BMY
$96B
| $1.16M | 0.14% | 19,689 +752 | +4% | +$44.2K |
|
70
Dollar General
DG
$23.9B
| $1.16M | 0.14% | 6,074 -506 | -8% | -$96.4K |
|
71
Eli Lilly
LLY
$657B
| $1.15M | 0.14% | +7,024 | New | +$1.15M |
|
72
Merck
MRK
$210B
| $1.13M | 0.14% | +14,636 | New | +$1.13M |
|
73
Applied Materials
AMAT
$128B
| $1.11M | 0.14% | 18,436 +65 | +0.4% | +$3.93K |
|
74
Nike
NKE
$114B
| $1.09M | 0.14% | +11,114 | New | +$1.09M |
|
75
Micron Technology
MU
$133B
| $1.09M | 0.14% | 21,095 +260 | +1% | +$13.4K |
|